Filing Flows › Glaukos (GKOS) › How it makes money
How Glaukos (GKOS) makes money
Glaukos (GKOS) made $211M of revenue in the third quarter 2026 (Q3 2026), +58% from a year earlier. Glaucoma brought in $152M (72%); Corneal Health brought in $59.0M (28%). Of every dollar of revenue, 85¢ was left as gross profit, 0¢ was left as operating profit, 1¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Glaucoma | $152M | 72.0% | -2% | +38% |
| Corneal Health | $59.0M | 28.0% | +94% | +154% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $211M | 100.0% |
| Cost of revenue | $31.2M | 14.8% |
| Gross profit | $180M | 85.2% |
| Operating expenses | $179M | 84.8% |
| Operating profit | $828K | 0.4% |
| Income tax | $303K | 0.1% |
| Net earnings | $2.0M | 1.0% |
| Operating cash flow | $38.6M | 18.3% |
| Free cash flow | $36.5M | 17.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $211M | +58% |
| Q2 2026 | $186M | +50% |
| Q1 2026 | $151M | +41% |
| Q4 2025 | $143M | +36% |
| Q3 2025 | $134M | +38% |
| Q2 2025 | $124M | +30% |
| Q1 2025 | $107M | +25% |
From Glaukos' 10-Q filed Oct 28, 2026 (on EDGAR).
Questions
How does Glaukos make money?
Glaukos (GKOS) made $211M of revenue in the third quarter 2026 (Q3 2026), +58% from a year earlier. Glaucoma brought in $152M (72%); Corneal Health brought in $59.0M (28%). Of every dollar of revenue, 85¢ was left as gross profit, 0¢ was left as operating profit, 1¢ was left as net earnings.
What is Glaukos' biggest business?
Glaucoma: $152M in the third quarter 2026, 72% of revenue, +38% from a year earlier.
What is Glaukos' profit margin?
Net earnings were $2.0M, 1.0% of revenue, in the third quarter 2026; the operating margin was 0.4%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.